HU173052B - Sposob poluchenija proizvodnykh tienil-karbamida - Google Patents

Sposob poluchenija proizvodnykh tienil-karbamida

Info

Publication number
HU173052B
HU173052B HU75DU237A HUDU000237A HU173052B HU 173052 B HU173052 B HU 173052B HU 75DU237 A HU75DU237 A HU 75DU237A HU DU000237 A HUDU000237 A HU DU000237A HU 173052 B HU173052 B HU 173052B
Authority
HU
Hungary
Prior art keywords
thienyl
producing
urea derivatives
urea
derivatives
Prior art date
Application number
HU75DU237A
Other languages
English (en)
Hungarian (hu)
Inventor
Paul E Aldrich
Bruce I Dittmar
Gilbert H Berezin
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of HU173052B publication Critical patent/HU173052B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU75DU237A 1974-04-17 1975-04-16 Sposob poluchenija proizvodnykh tienil-karbamida HU173052B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
HU173052B true HU173052B (hu) 1979-02-28

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
HU75DU237A HU173052B (hu) 1974-04-17 1975-04-16 Sposob poluchenija proizvodnykh tienil-karbamida

Country Status (21)

Country Link
US (1) US4009847A (en, 2012)
JP (1) JPS50148349A (en, 2012)
AR (1) AR208545A1 (en, 2012)
CA (1) CA1047042A (en, 2012)
CH (1) CH611292A5 (en, 2012)
DD (1) DD117223A5 (en, 2012)
DE (1) DE2516554A1 (en, 2012)
DK (1) DK164175A (en, 2012)
ES (1) ES436648A1 (en, 2012)
FI (1) FI751128A7 (en, 2012)
FR (1) FR2267773B1 (en, 2012)
GB (1) GB1461209A (en, 2012)
HU (1) HU173052B (en, 2012)
IE (1) IE41143B1 (en, 2012)
IL (1) IL47095A (en, 2012)
LU (1) LU72306A1 (en, 2012)
NL (1) NL7504570A (en, 2012)
NO (1) NO144071C (en, 2012)
PH (1) PH11722A (en, 2012)
SE (1) SE417965B (en, 2012)
YU (1) YU96075A (en, 2012)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) * 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US8124630B2 (en) * 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
HK1042251B (en) * 1999-01-13 2012-07-20 Bayer Healthcare Llc Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
RS52500B (en) * 2001-12-03 2013-04-30 Bayer Healthcare Llc Aryl of urea compounds in combination with other cytostatic or cytotoxic agents for the treatment of human cancers
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
WO2003068229A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
AU2003210969A1 (en) * 2002-02-11 2003-09-04 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
WO2003068746A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
ES2425739T3 (es) * 2002-02-11 2013-10-17 Bayer Healthcare Llc Sorafenib-tosilato para el tratamiento de enfermedades caracterizadas por angiogénesis anormal
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
PL1626714T3 (pl) * 2003-05-20 2007-12-31 Bayer Healthcare Llc Diarylowe pochodne mocznika do schorzeń, w których pośredniczy PDGFR
NZ580384A (en) * 2003-07-23 2011-03-31 Bayer Pharmaceuticals Corp 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
US7838524B2 (en) * 2004-04-30 2010-11-23 Bayer Healthcare Llc Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
FR2267773B1 (en, 2012) 1978-08-18
NO144071C (no) 1981-06-17
FR2267773A1 (en, 2012) 1975-11-14
NO144071B (no) 1981-03-09
YU96075A (en) 1983-04-27
US4009847A (en) 1977-03-01
JPS50148349A (en, 2012) 1975-11-27
IE41143L (en) 1975-10-17
CH611292A5 (en, 2012) 1979-05-31
PH11722A (en) 1978-05-30
SE417965B (sv) 1981-04-27
SE7503523L (sv) 1975-10-20
LU72306A1 (en, 2012) 1976-03-17
ES436648A1 (es) 1977-08-01
AU8013575A (en) 1976-10-21
IL47095A (en) 1978-03-10
NO751351L (en, 2012) 1975-10-20
GB1461209A (en) 1977-01-13
DD117223A5 (en, 2012) 1976-01-05
FI751128A7 (en, 2012) 1975-10-18
NL7504570A (nl) 1975-10-21
IL47095A0 (en) 1975-06-25
CA1047042A (en) 1979-01-23
AR208545A1 (es) 1977-02-15
DE2516554A1 (de) 1975-10-30
DK164175A (da) 1975-10-18
IE41143B1 (en) 1979-10-24

Similar Documents

Publication Publication Date Title
HU174077B (hu) Sposob poluchenija proizvodnykh dekapeptidamidakh
HU172653B (hu) Sposob poluchenija zamehhennykh 2-skobka-2-piridil-metil-sul'finil-skobka zakryta-benzimidazolov
HU172538B (hu) Sposob poluchenija metil-5-propiltio-2-benzimidazol-karbamata
HU173052B (hu) Sposob poluchenija proizvodnykh tienil-karbamida
HU173590B (hu) Sposob poluchenija proizvodnykh d-6-metil-8-tiometil-ehrgolina
HU172039B (hu) Sposob poluchenija proizvodnykh 2-fenil-indola
HU172103B (hu) Sposob poluchenija proizvodnykh 2-skobka-zamehhennykh-skobka zakryta-3-cianamino-3-skobka-zamehhennykh amino-skobka zakryta-propionitrilov
HU172906B (hu) Sposob poluchenija proizvodnykh alkil-amino-glikopiranozida
HU172431B (hu) Sposob poluchenija proizvodnykh fenola
YU40266B (en) Process for producing thienothiazepine derivatives
HU174005B (hu) Sposob poluchenija proizvodnykh analogov prostaglandina
HU173365B (hu) Sposob poluchenija olefin-polimerov
HU172493B (hu) Sposob poluchenija proizvodnykh tienobenzodiazepina
YU44833B (en) Process for producing 1-carboxyalkyltetrazol-5-thiole
HU171512B (hu) Sposob polucsenija proizvodnykh nikotinamid-adenin-dinukleotidov
HU172652B (en) Process for producing substituted 1-alkylamino-3-aryloxy-propan-2-ols
HU174252B (hu) Sposob poluchenija novykh aminofenilefirow
HU173609B (hu) Sposob poluchenija novykh proizvodnykh salicilanilida
HU173740B (hu) Sposob poluchenija proizvodnykh aza-digidro-prostaglandina
HU174348B (hu) Sposob poluchenija proizvodnykh 13-tia-prostaglandinov
HU174300B (hu) Sposob poluchenija proizvodnykh 1-acil-4-/o-galofenil/-tiosemikarbazida
HU172146B (hu) Sposob poluchenija proizvodnykh cinnolina
YU165781A (en) Process for producing penzopyran derivatives
HU171163B (hu) Sposob poluchenija proizvodnykh trans eburnamenina
YU326975A (en) Process for producing new dianhydro-hexyte derivatives